Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world’s most valuable health-care company even after it’s been crushing the S & P 500’s performance over the past three years. The study results released by Eli Lilly on Wednesday highlight the … Read more
Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016. Revenue for the three months ended March 31 rose slightly more than 2% year over year to $9.96 billion, … Read more
Shortly after the opening bell, we will be buying 100 shares of Abbott Laboratories at roughly $108.26. Following the trade, Jim Cramer’s Charitable Trust will own 800 shares of ABT, increasing its weighting to roughly 2.8% from 2.45%. Abbott Laboratories on Wednesday reported better-than-expected first-quarter earnings, but its stock is trading lower in the premarket, … Read more
Wall Street analysts on Monday issued a bearish call on Club holding Honeywell International , citing its lagging stock performance and sluggish growth prospects. We’re hopeful management can get the company back on track by reshaping its massive portfolio of far-flung businesses. Deutsche Bank downgraded Honeywell to hold from a buy rating and lowered the … Read more
We are buying 100 shares of Best Buy at roughly $75.28. Following the trade, Jim Cramer’s Charitable Trust will own 900 shares of BBY, increasing its weighting to roughly 2.15% from 1.94%. We’re making a third buy on Tuesday. Our general investing discipline is to put spare cash to work when the S & P … Read more
We are buying 300 shares of Coterra Energy at roughly $26.85 and 25 shares of Constellation Brands at roughly $255.56. Following the trades, Jim Cramer’s Charitable Trust will own 2,900 shares of CTRA, increasing its weighting to 2.5% from 2.23% and 375 shares of STZ, increasing its weighting to 3.05% from 2.85%. With the S … Read more
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets wobbly: After a weak attempt … Read more
Off-price is not going off-trend anytime soon. That might not be clear based on recent trading in TJX Companies’ stock. Club holding TJX Companies and rival Ross Stores are well-positioned to keep stealing market share from other retailers, particularly department stores, UBS said in a recent note, keeping a years-long trend in the industry alive. … Read more
Sales of some Eli Lilly drugs — including its best-selling product last year — appear to be softening, according to Wall Street analysts. But that might not be enough to stop its stock from climbing higher. Prescription data for multiple Eli Lilly drugs — especially type-2 diabetes treatment Trulicity — points to weaker trends in … Read more
Ford needs to close the gap with General Motors . We think Ford can do it by following GM’s lead on buybacks — plus, refining its mix of electric vehicles and hybrids as well as reining in warranty expenses. Shares of Club name Ford have gained about 7% year to date, lagging by far the … Read more
